|Bid||0.00 x 41800|
|Ask||0.00 x 1200|
|Day's Range||1.63 - 1.67|
|52 Week Range||1.38 - 2.80|
|PE Ratio (TTM)||1.41|
|Earnings Date||Sep 20, 2017 - Sep 25, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.97|
Moody's rating action reflects a base expected loss of 3.4% of the current pooled balance, compared to 3.2% at Moody's last review. For ratings issued on a support provider, this announcement provides certain regulatory disclosures in relation to the credit rating action on the support provider and in relation to each particular credit rating action for securities that derive their credit ratings from the support provider's credit rating.
Shares of Walgreens Boots Alliance (WBA) are down 16.5% over the last year based mostly on Amazon (AMZN) fears. There is no doubt that online selling and delivery have altered the retail world, but does that mean Walgreens can no longer compete? Let's dive into some of WBA's fundamentals to see what to do with the stock.
Rite Aid (RAD) gathers momentum on pending merger with Albertsons, the sale of assets to Walgreens, lesser debt burden and a robust outlook.
Earlier, we discussed how Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space. It’s very likely that these concerns have been picked up by the market, as the stocks of all major players in the space have lost considerable value.
Walgreens Boots Alliance (WBA) reported its fiscal third-quarter 2018 results on June 28. Its top line increased 14% YoY (year-over-year) to $34.3 billion. On a constant currency basis, sales were up 11.8% YoY.
In a June 28th press release, Amazon announced that it had signed an agreement to acquire online pharmacy start-up PillPack for an undisclosed amount. The news is big because PillPack has pharmacy licenses in all 50 states, so through PillPack, Amazon can essentially now begin its multi-year excursion into the massive U.S. pharmacy market. Shares of Amazon rose slightly.
Amazon (NASDAQ:AMZN) made waves on Thursday by announcing a deal to acquire online pharmacy PillPack in a $1 billion deal, beating out Walmart (NYSE:WMT) which was also in talks with the company.
Rite Aid’s (RAD) better-than-expected results drove its stock by 1.5% in the post-trading session on June 27. Its share price had risen a moderate 0.5% by the day’s close before it released its quarterly earnings results. The stock is likely to get a boost from its strong results today.
NEW YORK, NY / ACCESSWIRE / June 29, 2018 / U.S. markets rebounded Thursday on the strength of the financial and technology sectors. The Dow Jones Industrial Average jumped 0.41 percent to close at 24,216.05, ...
The e-commerce giant said it was acquiring online pharmacy PillPack, sending traditional pharmacy stocks like CVS Health (NYSE:CVS), Rite Aid (NYSE:RAD) and Walgreens Boots Alliance (NASDAQ:WBA) careening. Rather, the best bets from here are Sherwin-Williams (NYSE:SHW), Regeneron (NASDAQ:REGN) and Allstate (NYSE:ALL), each of which are relatively immune to the market’s normal recycling of hysteria.
Rite Aid (RAD) reported adjusted net income from continuing operations of -$11.5 million, or -$0.01 per share, in the fiscal first quarter of 2019 compared to an adjusted net income of -$9.2 million, or -$0.01 per share, in the same quarter of last year. The company, however, delivered results that were in line with Wall Street’s expectations.
The three companies lost an approximate $11 billion in market value on Thursday alone, while Amazon added more than $19.8 billion in market value thanks to the deal. PillPack is an online pharmacy that packages, organized and delivers presorted doses of medications and it’s designed to help patients who take multiple medications. The team at PillPack puts together your medications into daily packages that are easy to crack open and take all your daily medication at once so you don’t forget it earlier.
Investors don't seem to have much confidence in Walgreens Boots Alliance, and the drugstore chain hasn’t said much to ease their concerns.
Amazon's PillPack acquisition allows it to bypass some of the hurdles it would have to entering the retail pharmacy industry, Loop Capital's Anthony Chukumba said. On Wednesday, Loop raised its price target on Amazon to $1,900 from $1,800. Walgreens, CVS and Rite Aid are down on the news.
Online retail behemoth Amazon.com Inc. ( AMZN) has made its big splash in the U.S. health care industry with the acquisition of PillPack, an online prescription-drug company that packages, organizes and delivers presorted doses of medications. Manchester, New Hampshire-based PillPack indicates that it is licensed to ship prescriptions in 49 states. The news confirmed chatter surrounding Amazon's long-anticipated push into the multi-billion-dollar pharmacy space, wherein over 4 billion prescriptions are ordered in the U.S. per year.
Shares of pharmacy giants CVS (CVS), Rite Aid (RAD), and Walgreens Boots Alliance (WBA) all plummeted on Thursday morning after Amazon (AZMN) announced its purchase of online pharmacy delivery startup PillPack. The move clearly has some investors worried that Amazon's push into the pharmaceutical industry will hurt the current powers. So let's take a look at more of the details to find out what's really going on.
Amazon is officially getting into the health care business and buying online pharmacy PillPack, reportedly the deal is worth about $1 billion.
Pharmacies get 'Amazoned'. What does it mean to their stocks down the road? With CNBC's Bob Pisani and Melissa Lee, and the Fast Money traders, Tim Seymour, Karen Finerman, Dan Nathan and Brian Kelly.